Amazon is scaling up its Zoox robotaxi production near Silicon Valley, aiming for 10,000 units annually to rival Waymo. With a massive factory and innovative designs, Amazon enters a competitive race alongside Tesla, promising to transform urban mobility with autonomous technology.
Social Security faces a critical shortfall by 2034, potentially cutting benefits for millions of retirees and disabled individuals. Without Congressional action, the program’s trust fund could be depleted, risking financial hardship. Urgent reform is needed to protect this vital safety net.
US regulators plan to cut capital buffers by up to 1.5 percentage points for major banks, aiming to boost trading in the $29 trillion Treasury market. This move addresses liquidity concerns but raises questions about financial stability.
Oil prices surged over 4% amid fears of U.S. involvement in an Israel-Iran conflict, shaking global markets. U.S. stocks fell as investors sought safer assets, while concerns over energy supply disruptions grow. The crisis highlights the fragility of economic stability in times of geopolitical tension.
Japan faces a trade deficit as exports drop 1.7% in May, with auto shipments to the U.S. falling 25% due to Trump’s tariffs. This economic challenge prompts Japan to diversify markets and rethink strategies amid global trade tensions.
Bitcoin treasury companies pose unique challenges for auditors due to cryptocurrency volatility, blockchain complexities, and regulatory uncertainty. As businesses increasingly adopt digital assets, financial experts must navigate uncharted territory to ensure transparency, highlighting the urgent need for new auditing approaches in the evolving world of crypto finance.
A discussion on baby boomers passing homes to millennials sparked Gen X backlash, revealing their frustration as the overlooked ‘Sandwich Generation.’ This generational tension highlights the complex emotions and financial challenges tied to real estate inheritance.
The FDA’s new voucher program aims to review select drugs in just one to two months. While it promises faster access to treatments, critics warn of safety risks and potential inequities. Can speed and rigor coexist in drug approvals?
ProPublica has sued the FDA for withholding records on generic drug safety, spotlighting transparency issues in the pharmaceutical industry. The lawsuit, tied to foreign manufacturing concerns, could impact public trust and regulatory practices as millions rely on these drugs daily.
A Trump-branded smartphone, likely made in China, faces potential tariffs from the administration’s own policies. Experts doubt U.S. manufacturing feasibility, highlighting global supply chain challenges and cost implications for consumers.
